estradiol FDA Alerts
The FDA Alert(s) below may be specifically about estradiol or relate to a group or class of drugs which include estradiol.
MedWatch Safety Alerts are distributed by the FDA and published by Drugs.com. Following is a list of possible medication recalls, market withdrawals, alerts and warnings. For the latest FDA MedWatch alerts, go here.
Recent FDA Alert(s) for estradiol
Olympia Pharmacy Sterile Compounded Products: Recall - Concerns About Sterility Assurance
May 30, 2013
ISSUE: Lowlite Investments d/b/a Olympia Pharmacy ("Lowlite") notified the public of a voluntary multi-state recall of all sterile drug products compounded by the pharmacy that have not reached the expiration date listed on the product. The recall is being initiated due to concerns associated with prior quality control procedures that impacted sterility assurance. In the event a sterile product is compromised patients are at risk for serious and possible life threatening infections.
The recall includes all sterile products that Olympia Pharmacy supplied to patients and offices of licensed medical professionals with a use by date of 09/25/2013 or earlier. Olympia Pharmacy will be notifying customers by phone, fax, or mail to return the products to the pharmacy.
BACKGROUND: To date, Lowlite has received no reports of injury or illness associated with the use of the affected products.
RECOMMENDATION: Consumers or health care providers with questions regarding this recall may contact Lowlite by phone at 888-323-7788 or 407-673-2222 from the hours of 9:00AM- 6:00PM Eastern Daylight Time Monday through Friday, or at the following e-mail address: Brian@olympiapharmacy.com. Patients who have received any product furnished by Lowlite and have concerns should contact their healthcare provider.
Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:
- Complete and submit the report Online: www.accessdata.fda.gov/scripts/medwatch/index.cfm
- Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
Injectable drugs prepared by Urgent Care Pharmacy
Nov 18, 2002
Audience: All healthcare professionalsThe Food and Drug Administration (FDA) announced a nationwide alert concerning all injectable drugs prepared by Urgent Care Pharmacy of Spartanburg, South Carolina, based on the lack of assurance that their products are sterile. Non-sterility of injectable products can represent a serious hazard to health that could lead to life-threatening injuries and death. FDA inspection of Urgent Care's facility revealed the firm failed to have adequate controls to ensure necessary sterility, including the absence of appropriate testing for potency and sterility prior to distribution.
FDA is aware that Urgent Care has distributed the following injectable drugs to physicians, hospitals, clinics and consumers in Connecticut, Illinois, Indiana, Kentucky, Louisiana, Massachusetts, Mississippi, New Hampshire, North Carolina, South Carolina and Virginia: Baclofen, Betamethasone, Bimix 30:1, (Phentolamine mesylate/papaverine), Clonidine, Estradiol, Hydromorphone HCl, Fentanyl, methylprednisolone acetate, Morphine Sulfate/Bupivacaine, Papaverine HCl, Super Trimix (Papaverine HCl/phentolamine mesylate/prostaglandin), Testosterone cypionate, Testosterone/Estradiol.
[November 15, 2002 Talk Paper - FDA]
More estradiol Resources
- Estradiol Consumer Information
- Estradiol Consumer Information
- Estradiol injection Consumer Information
- Estradiol topical for use on skin Consumer Information
- Estradiol transdermal Consumer Information
- Estradiol vaginal Consumer Information
- Estradiol Gel (Divigel) Consumer Information
- Estradiol Gel (Elestrin) Consumer Information
- Estradiol Gel (EstroGel) Consumer Information
- Estradiol Injection Consumer Information
- Estradiol Oral Tablets Consumer Information
- Estradiol Transdermal Biweekly Patch Consumer Information
- Estradiol Transdermal Spray Consumer Information
- Estradiol Transdermal Weekly Patch Consumer Information
- Estradiol Transdermal Weekly Patch (Osteoporosis) Consumer Information
- Estradiol Vaginal Ring (Femring) Consumer Information
- Estradot Transdermal Therapeutic System Transdermal Advanced Consumer Information
- Estring Vaginal Advanced Consumer Information
- Imvexxy Vaginal Advanced Consumer Information
- Rhoxal-Estradiol Derm 50 Transdermal Advanced Consumer Information
- Rhoxal-Estradiol Derm 75 Transdermal Advanced Consumer Information
- Roxal-Estradiol Derm 100 Transdermal Advanced Consumer Information
- Vagifem Vaginal Advanced Consumer Information
- Vivelle 100 Mcg Transdermal Advanced Consumer Information
- Vivelle 25 Mcg Transdermal Advanced Consumer Information
- Vivelle 37.5 Mcg Advanced Consumer Information
- Estradiol Transdermal Advanced Consumer Information
- Estradiol Vaginal Advanced Consumer Information
- Estradiol AHFS DI Monograph
- Estradiol Prescribing Information
- Estradiol Valerate Injection Prescribing Information
- Estring Prescribing Information
- Guna-Beta-Estradiol Prescribing Information
- Innofem Prescribing Information
- Estradiol (Systemic) A-Z Drug Facts